Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE10A | Q9Y233 | 6/20 | 0.37 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | KDM5A | P29375 | 1/20 | 0.31 |
| ▸ | CCR2 | P41597 | 1/20 | 0.31 |
| ▸ | PDE9A | O76083 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27040028 | 1.00 | PDE10A (0.37) | PDE10ATRPV3MAPK1KDM5ACCR2 | |
| SCHEMBL744363 | 0.79 | PDE10A (0.50) | PDE10ATRPV3MAPK1 | |
| SCHEMBL30408061 | 0.79 | PDE10A (0.50) | PDE10ATRPV3MAPK1 | |
| SCHEMBL29765569 | 0.78 | — | — | |
| SCHEMBL16060787 | 0.78 | — | — | |
| SCHEMBL17336360 | 0.78 | PDE9A (0.39) | PDE10AMAPK1KDM5APDE9A | |
| SCHEMBL17675448 | 0.75 | CYP11B2 (0.42) | KDM5APDE9A | |
| SCHEMBL634218 | 0.74 | OGA (0.42) | PDE10A | |
| SCHEMBL277675 | 0.73 | CYP11B2 (0.46) | MAPK1KDM5APDE9A | |
| SCHEMBL31119419 | 0.73 | CYP11B2 (0.46) | MAPK1KDM5APDE9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4559908-A1 | HETEROARYL DERIVATIVE COMPOUND AND USE THEREOF | S2CBio Inc. (KR) | 2025-05-28 | — | — | EP | disclosed |
| WO-2024058617-A1 | ANTIVIRAL USE OF HETEROARYL DERIVATIVE COMPOUND | 일동제약(주) | 2024-03-21 | — | — | WO | disclosed |
| WO-2024019541-A1 | HETEROARYL DERIVATIVE COMPOUND AND USE THEREOF | 일동제약(주) | 2024-01-25 | — | — | WO | disclosed |